Metraipolis › archive › dc_889a45f285d9

Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease — Europe PMC PMID:41012644

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012644
DOI
10.3390/v17091216
License (as archived)
solo-consultazione
Archived
2026-11-10T02:23:21.688Z
SHA-256 of the archived text
f7f9f437b9f78ed30b165a0102b29aad28cf8284918c66fb6e305b89161dfb32
Stable URL of this page
https://metraipolis.com/documento/dc_889a45f285d9

How to cite

Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease — Europe PMC PMID:41012644 — Europe PMC (en), https://europepmc.org/article/MED/41012644 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_889a45f285d9 (Metraipolis archive dc_889a45f285d9, sha256 f7f9f437b9f78ed30b165a0102b29aad28cf8284918c66fb6e305b89161dfb32)
BibTeX
@misc{dc889a45f285d9,
  title = {Tixagevimab-Cilgavimab Effectively Prevents COVID-19 Infection in Patients with End-Stage Kidney Disease — Europe PMC PMID:41012644},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012644},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_889a45f285d9; sha256 f7f9f437b9f78ed30b165a0102b29aad28cf8284918c66fb6e305b89161dfb32},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012644. Agents can read the archived copy with the MCP tool read_document.